LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Carl Zeiss Acquires Bio-Rad's Cell Science Division

By Biotechdaily staff writers
Posted on 15 Jun 2004
In a move that will enlarge its microscopy business, Carl Zeiss (Oberkochen, Germany) has acquired the Cell Science Division (Hemel Hempstead, UK) of Bio-Rad Laboratories, Inc. (Hercules, CA, USA). Terms were not disclosed.

This strategic move is part of the ongoing investment in enhancing the application expertise at Carl Zeiss, according to the company. The acquisition is expected to accelerate future advances in confocal and multiphoton microscope instrumentation with Carl Zeiss as the major driving force in the field.

"Today, Carl Zeiss stands for high-end laser scanning microscopes that are benchmark solutions for advanced applications in 3-D microscopy,” said Dr. Ulrich Simon, head of the microscopy business group at Carl Zeiss. "Joining our forces will strengthen our relationship with Zeiss and Bio-Rad customers, and will allow a considerable additional refinement of both companies' worldwide service and support network.”





Related Links:
Carl Zeiss
Bio-Rad

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
15 Jun 2004  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
15 Jun 2004  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
15 Jun 2004  |   BioResearch